SPC323
Remdesivir eða lyfjafræðilega viðeigandi salt þess
Status:
VeittApplication date:
18.12.2020Application published:
15.1.2021Grant published:
15.11.2021
Max expiry date:
21.10.2034Medicine name:
VekluryMedicine for children:
Yes
Timeline
Today
18.12.2020Application
15.1.2021Publication
15.11.2021Registration
21.10.2034Expires
Marketing license
IS authorization number:
EU/1/20/1459/001 & EU/1/20/1459/002Date:
3.7.2020
Foreign authorization number:
EU/1/20/1459Date:
3.7.2020
Owner
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, Foster City, CA US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2937350
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 12.10.2025